Commentary

Evaluating the impact of FDA’s pregnancy and lactation labeling rule


 

Dr. Chambers is a professor of pediatrics and director of clinical research at Rady Children’s Hospital, and associate director of the Clinical and Translational Research Institute at the University of California, San Diego. She is director of MotherToBaby California, a past president of the Organization of Teratology Information Specialists, and past president of the Teratology Society. She has no relevant financial disclosures. To comment, e-mail her at obnews@frontlinemedcom.com.

Pages

Recommended Reading

Nitrous oxide for labor pain
MDedge ObGyn
Does this new evidence for noninvasive prenatal testing to detect fetal aneuploidy move NIPT closer to universal use in pregnancy?
MDedge ObGyn
Exclusively breastfed neonate weight loss graphed
MDedge ObGyn
Uterus ruptures at home: My most memorable experience of a transferred home birth
MDedge ObGyn
VIDEO: Family physicians can fill rural maternity care gaps
MDedge ObGyn
FDA issues new pregnancy/lactation drug label standards
MDedge ObGyn
CDC seeks comment on draft circumcision guidance
MDedge ObGyn
Consider biopsy for active lupus nephritis in pregnancy
MDedge ObGyn
Watchful waiting is viable option for unruptured ectopic pregnancies
MDedge ObGyn
Nearly 9% of Medicaid-financed births are early elective deliveries
MDedge ObGyn

Related Articles